TY  - JOUR

T1  - Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

JO  - Intensive Care Medicine

UR  - https://doi.org/10.1007/s00134-021-06448-5

PY  - 2021/07/12

AU  - Arabi YM

AU  - Gordon AC

AU  - Derde LPG

AU  - Nichol AD

AU  - Murthy S

AU  - Beidh FA

AU  - Annane D

AU  - Swaidan LA

AU  - Beane A

AU  - Beasley R

AU  - Berry LR et al

ED  - 

DO  - DOI: 10.1007/s00134-021-06448-5

PB  - Springer Science and Business Media LLC

VL  - 47

IS  - 8

SP  - 867

EP  - 886

Y2  - 2025/07/22

ER  -